Cargando…
Defining the molecular pathology of pancreatic body and tail adenocarcinoma
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a dismal disease, with very little improvement in survival over the past 50 years. Recent large-scale genomic studies have improved understanding of the genomic and transcriptomic landscape of the disease, yet very little is known about mol...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817249/ https://www.ncbi.nlm.nih.gov/pubmed/29341146 http://dx.doi.org/10.1002/bjs.10772 |
Ejemplares similares
-
Reevaluation of regional lymph nodes in patients with pancreatic ductal adenocarcinoma in the pancreatic body and tail
por: Matsui, Yuki, et al.
Publicado: (2022) -
A Rare Case of Pancreatic Tail Hydatid Cyst with Incidental Adenocarcinoma of the Pancreatic Body
por: Zarbaliyev, Elbrus, et al.
Publicado: (2019) -
Adjuvant therapy for pancreatic body or tail adenocarcinoma: a study of the National Cancer Database
por: Seaton, Max, et al.
Publicado: (2019) -
Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages
por: Zhang, Xueyou, et al.
Publicado: (2021) -
Tumors of the Pancreatic Body and Tail
por: Barreto, Savio George, et al.
Publicado: (2010)